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Abstract. 
 
To explore the role of GTPases in endocyto-
sis, we developed an assay using 
 
Xenopus
 
 oocytes in-
jected with recombinant proteins to follow the uptake 
of the fluid phase marker HRP. HRP uptake was inhib-
ited in cells injected with GTP
 
g
 
S or incubated with alu-
minum fluoride, suggesting a general role for GTPases 
in endocytosis. Injection of Rab5 into oocytes, as well 
as Rab5:Q79L, a mutant with decreased GTPase activ-
ity, increased HRP uptake. Injection of Rab5:S34N, the 
dominant-negative mutant, inhibited HRP uptake. In-
jection of 
 
N
 
-ethylmaleimide–sensitive factor (NSF) 
stimulated HRP uptake, and ATPase-defective NSF 
mutants inhibited HRP uptake when coinjected with 
Rab5:Q79L, confirming a requirement for NSF in en-
docytosis. Surprisingly, injection of Rab7:WT stimu-
lated both uptake and degradation/activation of HRP. 
The latter appears to be due to enhanced transport to a 
late endosomal/prelysosomal degradative compartment 
that is monensin sensitive. Enhancement of uptake by 
Rab7 appears to function via an Rab5-sensitive path-
way in oocytes since the stimulatory effect of Rab7 was 
blocked by coinjection of Rab5:S34N. Stimulation of 
uptake by Rab5 was blocked by Rab5:S34N but not by 
Rab7:T22N. Our results suggest that Rab7, while func-
tioning downstream of Rab5, may be rate limiting for 
endocytosis in oocytes.
G
 
tp 
 
binding proteins are versatile molecular switches
(Bourne, 1988; Bourne et al., 1990), and during
the past few years, there has been an explosion of
interest in unraveling the role of these proteins, particu-
larly low molecular weight GTPases, in membrane traffic
(Balch, 1990; Barr et al., 1992). Evidence from a variety of
sources, including the temperature-sensitive secretion mu-
tants in yeast and in vitro reconstitution experiments in
permeabilized and broken cell preparations, has estab-
lished that at least two subfamilies of GTP binding pro-
teins, namely the Rab and ADP ribosylation factor sub-
families, are required for membrane traffic (Pfeffer, 1994;
Rothman, 1994). Heterotrimeric GTPases (Colombo et
al., 1992) and ras (Barsagi and Feramisco, 1986) also appear
to play significant roles.
Among the monomeric small GTPases, the Rab family
is well characterized as regulators of intracellular traffick-
ing during endocytosis and secretion (Zerial and Sten-
mark, 1993). Rab proteins are specifically localized to the
cytoplasmic surface of the intracellular compartments that
they subserve, such as ER (Rab1 and Rab2) (Chavrier et al.,
1990; Tisdale et al., 1992), 
 
cis
 
-Golgi (Rab1 and Rab2)
(Chavrier et al., 1990; Tisdale et al., 1992), medial Golgi
(Rab6) (Goud et al., 1990), 
 
trans
 
-Golgi (Rab9) (Gravotta
et al., 1990; Lombardi et al., 1993), early endosomes (Rab4
and Rab5) (Chavrier et al., 1990; van der Sluijs et al., 1991),
late endosomes (Rab7 and Rab9) (Chavrier et al., 1990;
Lombardi et al., 1993; Feng et al., 1995), and plasma mem-
brane/endosomes (Rab5) (Chavrier et al., 1990).
In transient transfection experiments and in vitro fusion
assays using enriched membrane preparations, Rab5 has
been shown to play a role in the regulation of endocytosis
(Grovel et al., 1991; Li and Stahl, 1993). Overexpression of
Rab5 increases the rate of endocytosis and the recycling of
the transferrin receptor. Moreover, Rab5-specific antise-
rum and Rab5 dominant-negative mutants specifically in-
hibit endosome fusion in vitro (Bucci et al., 1992; Li et al.,
1994; Barbieri et al., 1994). While it has been shown that
Rab5 regulates endocytosis at the level of early endosome
fusion, the mechanism by which Rab5 exerts its function
remains to be established. Moreover, transport of macro-
molecules along the endocytic pathway requires a series of
highly coordinated and specific fusion events involving
multiple cytosolic and membrane-bound factors including
the 
 
N
 
-ethylmaleimide–sensitive factor (NSF)
 
1
 
 (Diaz et al.,
1988; Rothman, 1994) and a membrane-bound trypsin-sen-
sitive factor (Colombo et al., 1991). Protein phosphorylation
has also been shown to regulate the fusion of endosomal
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1.
 
 Abbreviations used in this paper
 
: GST, glutathione-
 
S
 
-transferase; MBS,
modified Barth’s saline; NSF, 
 
N
 
-ethylmaleimide–sensitive factor; WT,
wild type.
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vesicles (Toumikoski et al., 1989). Certain lipids may also
play a role in membrane docking and fusion. Both PLA
 
2
 
(Mayorga et al., 1993) and PI3 kinase (Li et al., 1995) are in-
timately involved in the regulation and/or action of Rab5.
However, the exact relationship among all these factors in
the overall mechanism of intracellular trafficking during
endocytosis is largely unknown.
Both fluid phase and receptor-mediated endocytosis oc-
cur through vesicle fusion and transfer of endocytic mate-
rials from one compartment to another in a highly regu-
lated fashion. Depending on the receptor system, ligands
and receptors are internalized and sorted in the early en-
dosomal compartment (Goldstein et al., 1985), often re-
quiring acidic pH, and selected molecules are recycled back
to the plasma membrane. Some are transported to the late
endosomal compartment that may communicate with the
 
trans
 
-Golgi network or the lysosomal compartment (Ya-
mashiro et al., 1984). The late endosome represents the
convergence point of several pathways such as (
 
a
 
) the tar-
geting of newly synthesized lysosomal enzymes and lyso-
somal membrane proteins to the lysosome (Griffiths et al.,
1990; Riederer et al., 1994), (
 
b
 
) the killing of internalized
microorganisms by phagocytes (Ludwig et al., 1991; Ra-
binowitz et al., 1992; Desjardins et al., 1994; Beron et al.,
1995), and (
 
c
 
) the processing and presentation of antigens
where major histocompatibility complex class II molecules
are recycled to the plasma membrane after the formation
of peptide–major histocompatibility complex class II com-
plex in the late endosomal compartment (Cresswell, 1994;
Germain, 1994; Qui et al., 1994). It is now clear that multi-
ple Rab proteins, including Rab7, Rab9, and Rab24, and
perhaps others to be identified, are associated with the late
endosomal compartment (Chavrier et al., 1990; Lombardi
et al., 1993; Olkkonen et al., 1993). Rab9 has been shown
to regulate the traffic from the late endosome to the TGN
(Lombardi et al., 1993; Riederer et al., 1994), and Rab7 has
been shown to regulate the traffic from early to late endo-
somes (Wichmann et al., 1992; Feng et al., 1995) or from
late endosomes to vacuoles (Schimmoller et al., 1993; Hass
et al., 1995). Considerable progress has been made toward
understanding the regulation of transport by specific Rabs,
each with its own family of effector proteins. However, the
relation of one Rab to another and the regulation of intra-
cellular pathways made up of a series of relays is poorly
understood. In the present investigation, we have ex-
ploited the 
 
Xenopus
 
 oocyte as a model system to study the
regulation of endocytosis by multiple Rabs. Our data sug-
gest that the action of one Rab may influence the function
of a second Rab acting downstream.
 
Materials and Methods
 
mAbs used in this study include: 4F11, a mouse 1 g G2a
 
K
 
 mAb that recog-
nizes mouse Rab5, generously provided by A. Wandinger-Ness (North-
western University, Evanston, IL), and A46, a mouse IgM mAb that rec-
ognizes native NSF, kindly provided by J.E. Rothman (Sloan-Kettering
Memorial Hospital, New York). Irrelevant IgG and IgM mAbs were pur-
chased from Sigma Chemical Co. (St. Louis, MO) and used as control. Re-
combinant NSF wild-type and mutant proteins were generously provided
by S.W. Whiteheart (University of Kentucky, Lexington). HRP-conju-
gated antibodies and enhanced chemiluminescence detection reagents were
from Amersham Corp. (ECL; Arlington Heights, IL). All other reagents
were from Sigma Chemical Co.
 
Preparation of Oocytes
 
Ovaries were dissected from adult female 
 
Xenopus laevis
 
 (Nasco, Fort At-
kinson, WI) anesthetized with 3-aminobenzoic acid ethyl ester (1 g/liter)
in ice water. The ovaries were agitated gently for 2 h in modified Barth’s
saline (MBS) containing no calcium with 2 mg/ml type 1 collagenase at
room temperature (Swick et al., 1992). After collagenase treatment, the
oocytes were washed six times in MBS containing 5% BSA. Cells ob-
tained in this manner were incubated overnight in MBS with BSA and
gentamycin (50 
 
m
 
g/ml) at 4
 
8
 
C.
 
Expression and Purification of Recombinant Rabs
and Mutants
 
The Rab5 fusion proteins used in this study including Rab5:Q79L, Rab5:
S34N, and Rab5:
 
D
 
C4 were described previously (Li and Stahl, 1993; Li et al.,
1994). Rab7 wild type (WT) and Rab7:T22N were expressed and purified
as glutathione-
 
S
 
-transferase (GST) fusion protein as described for Rab5
(Li and Stahl, 1993; Li et al., 1994). To prepare fusion proteins, cDNAs were
amplified by 25 cycles of PCR and subcloned into unique BamH1/EcoR1
restriction sites of the bacteria expression vector pGEX-3X (Pharmacia
Biotech Inc., Piscataway, NJ). Recombinant proteins were expressed in
large quantities as GST fusion proteins in 
 
Escherichia coli
 
 strain JM 101.
GST fusion proteins were affinity purified with glutathione–Sepharose.
 
Microinjection of Test Proteins in Xenopus Oocytes
and HRP Uptake
 
Before microinjection, healthy oocytes (stage V or VI) were visually se-
lected. Oocytes were injected with the indicated concentrations of test mole-
cules in 50 nl of buffer A (20 mM Hepes, pH 7.4, containing 20 mM NaCl,
1 mM MgCl
 
2
 
, and 100 
 
m
 
M ATP), and then allowed to recover in MBS at
18
 
8
 
C for 2 h. Finally, healthy oocytes were selected for HRP uptake. The
injected oocytes were incubated in the presence of HRP (2 mg/ml) for 1 h
at 18
 
8
 
C. HRP uptake by the oocytes was stopped by washing the cells
three times with MBS containing 5% BSA. Individual oocytes were then
lysed in 200 
 
m
 
l PBS containing 0.1% Triton X-100 and centrifuged, and
the lysate was assayed for HRP. The enzyme assay was conducted in a 96-
well plate (Costar Corp., Cambridge, MA) using 
 
o
 
-phenylenediamine as
the chromogenic substrate (Wolters et al., 1976). Briefly, the reaction was
initiated by adding 5 
 
m
 
l of the lysate to 100 
 
m
 
l of 0.05 N sodium acetate
buffer, pH 5.0, containing 
 
o
 
-phenylenediamine (0.75 mg/ml) and H
 
2
 
O
 
2
 
(0.006%). After incubation (5 min at room temperature), the reaction was
stopped with 0.1 N H
 
2
 
SO
 
4
 
. The products were quantified by measuring the
OD 490 nm in a microplate reader (Bio Rad Laboratories, Hercules, CA).
Results were expressed as ng of HRP uptake per oocyte.
 
Western Blot Analysis of Rab5 and Mutants
 
Oocytes were injected with Rab5:Q79L or Rab5:
 
D
 
C4 (100 ng in 50 nl of
buffer A) and incubated for 2 h at 18
 
8
 
C. The cells were then lysed, and
crude membrane and cytosolic fraction were prepared by centrifuging at
70,000 rpm for 15 min in a TL-100 ultracentrifuge (Beckman Instruments,
Inc., Palo Alto, CA). Each fraction (5 
 
m
 
g) was separated by SDS-PAGE
and transferred onto nitrocellulose membranes, and Western blot analysis
was carried out using polyclonal anti-Rab5 antibody and developed by en-
hanced chemiluminescence.
 
Degradation Assay Using Preloaded HRP in Oocytes
 
To monitor the inactivation/degradation of the marker protein, oocytes
were preloaded with HRP (2 mg/ml) in MBS for 1 h at 18
 
8
 
C. Subse-
quently, cells were washed three times with ice-cold MBS to remove un-
bound HRP. HRP-preloaded cells were injected with the test proteins and
incubated for 2 h at 18
 
8
 
C. The amount of HRP activity present after the
incubation was determined after lysis of the oocytes.
To follow degradation, oocytes were incubated with 
 
125
 
I-HRP (500 
 
m
 
g/ml;
2 
 
3
 
 10
 
5
 
 cpm/
 
m
 
g) for 1 h at 18
 
8
 
C. The cells were then washed to remove un-
bound radioactivity. The preloaded cells were injected either with control
buffer or Rab proteins and incubated in MBS for 2 h at 18
 
8
 
C, the media
were collected, and the cells were lysed. TCA-soluble and -precipitable ra-
dioactivity both in the cell lysates and in the medium was determined by
addition of 10% TCA followed by centrifugation.
 o
n
 N
ovem
ber 21, 2011
jcb.rupress.org
D
ow
nloaded from
 
Published March 24, 1997
 Mukhopadhyay et al. 
 
Rab GTPases and Oocyte Endocytosis
 
1229
 
Confocal Microscopy
 
For confocal microscopy, oocytes were injected with Rab7 or mutant pro-
teins and allowed to recover for 1 h at 18
 
8
 
C. The cells were then incubated
with HRP-FITC for 1 h at room temperature under slow rotation in the
dark. Subsequently, the cells were washed three times with MBS and incu-
bated in the dark for one additional hour. The labeled oocytes were then
observed with an MRC 600 laser confocal microscope (Bio Rad Micro-
science, Cambridge, MA) using a 
 
3
 
63 plan apochromat oil immersion ob-
jective (Carl Zeiss, Inc., Thornwood, NY).
 
Results
 
Role of GTPases in Endocytosis in Xenopus Ooocytes
 
To determine the function of GTPases in the endocytic
pathway, we used HRP as a marker to follow endocytosis
and transport from the cell surface to a lysosomal com-
partment. The results presented in Fig. 1 show that HRP
uptake is linear with time when the cells are incubated
with HRP at 2 mg/ml. All subsequent uptake experiments
were carried out for 1 h with 2 mg/ml HRP. Many experi-
ments were also carried out at a higher ligand concentra-
tion (5 mg/ml) with identical results.
To determine the role of GTPases in intracellular traf-
ficking, we measured HRP uptake by oocytes after injec-
tion of GTP
 
g
 
S, a nonhydrolyzable analogue of GTP. About
80% inhibition of HRP uptake was obtained when GTP
 
g
 
S
(20 
 
m
 
M; 50 nl per cell) was injected, suggesting that one or
more GTPases are involved in endocytosis in oocytes (data
not shown). HRP uptake was also inhibited by aluminum
fluoride (data not shown) but was not significantly af-
fected when the cells were microinjected with equivalent
concentrations of aluminum sulfate or potassium fluoride.
These results provide evidence for a role for heterotrimeric
GTPases in endocytosis in oocytes (Mayorga et al., 1989;
Chabre, 1990; Colombo et al., 1994).
 
Effect of Injected Rab GTPases on Oocyte Endocytosis
 
To explore the role of Rab GTPases in endocytosis in 
 
Xe-
nopus
 
 oocytes, we microinjected different Rab proteins
(100 ng) and followed HRP uptake. Both Rab5 and Rab7
significantly stimulated HRP uptake by oocytes by 1.5- to
twofold (Fig. 2). This result is consistent with the finding
that Rab5 stimulates endocytosis during transient expres-
sion in vivo and endosome–endosome fusion in vitro (Li
and Stahl, 1993; Bucci et al., 1992; Li et al., 1994; Barbieri
et al., 1994; Stenmark et al., 1994). The stimulation of HRP
uptake by Rab7 was an unexpected but interesting obser-
vation. Injection of Rab4 had no effect on HRP endocyto-
sis. We studied four different constructs of Rab5: Rab5:
S34N, a dominant-negative mutant (Li and Stahl, 1993;
Grovel et al., 1991; Burstein et al., 1992); Rab5:
 
D
 
C4 where
the isoprenylation motif is deleted; Rab5:Q79L, a GTPase-
defective mutant (Li et al., 1994; Burstein et al., 1992); and
Rab5:wild type. All the proteins were prepared as GST fu-
sion proteins and the purified proteins were injected di-
rectly into oocytes. As shown in Fig. 3 
 
a
 
, both Rab5:WT
and Rab5:Q79L enhanced uptake of HRP. Rab5:S34N, on
the other hand, markedly inhibited HRP uptake by the oo-
cytes (Fig. 3 
 
a
 
). Rab5:
 
D
 
C4 failed to associate with mem-
Figure 1. Time-dependent uptake of HRP by the oocytes. Oo-
cytes were incubated with 2 mg/ml of HRP for different periods
of times. The cells were washed three times with MBS and each
oocyte was lysed in 200 ml of lysis buffer. Aliquots of the lysate
were used to measure the amount of HRP present in each cell.
The results, expressed as ng of HRP per oocyte, represent the av-
erage of eight independent observations.
Figure 2. Effect of different Rab proteins on HRP uptake in oo-
cytes. Oocytes were injected with 100 ng of the indicated Rabs in
50 nl of microinjection buffer and incubated for 2 h at 188C. The
cells were then incubated with HRP (2 mg/ml) for 1 h at 188C to
determine the uptake rate. Results were expressed as percentage
of uptake per oocyte with respect to control (220 ng per oocyte) 6
SD (average of eight experiments).
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branes and did not significantly affect HRP uptake. Rab5:
DC4 was present exclusively in the cytosolic fraction (Fig.
3 
 
b
 
). These results strongly suggest that frog oocytes have
the ability to carry out the required posttranslational mod-
ification of Rab proteins, and that COOH-terminal isopren-
ylation is required for the binding of the Rab GTPase to
the target membrane and for biological activity. Moreover,
we have also found that Rab proteins are readily prenylated
in vitro using oocyte cytosol in the presence of labeled
substrate (data not shown). To confirm that the stimula-
tory effect of Rab5:Q79L was due to the injected Rab pro-
tein, coinjection experiments were carried out with the
Rab fusion protein and an anti-Rab5 antibody. Coinjec-
tion of the fusion protein with anti-Rab5 antibody, but not
with a control antibody, dramatically inhibited Rab5:
Q79L-enhanced uptake of HRP (Fig. 4).
 
Role of NSF in Rab5-Stimulated Endocytosis of HRP
 
NSF is required for in vitro endosome fusion (Diaz et al.,
1989). To delineate the role of NSF in endocytosis in oo-
cytes, we injected anti-NSF antibody into the cells and
measured HRP uptake. The results presented in Fig. 5 
 
a
 
demonstrate that anti-NSF antibody inhibits the stimula-
tion of HRP uptake in cells injected with Rab5:Q79L when
anti-NSF antibodies and Rab5:Q79L were coinjected. In-
jection of anti-NSF antibodies in control oocytes resulted
in a modest reduction in uptake (data not shown). To con-
firm the participation of NSF in Rab5 function, we coin-
jected oocytes with Rab5:Q79L and His
 
6
 
NSF wild-type
protein. The results in Fig. 5 
 
b
 
 show that Rab5:Q79L-stim-
ulated HRP uptake is enhanced in the presence of NSF
protein. NSF is a heterotrimer whose polypeptide subunits
are made up of three distinct domains: an amino-terminal
domain and two homologous ATP (D1 and D2) binding
domains (Whiteheart et al., 1994). The ability of the D1
domain to hydrolyze ATP is required for NSF-mediated
membrane fusion. The D2 domain is required for trimer-
ization, but its ability to hydrolyze ATP is not absolutely
required for NSF function. Two distinct mutations in the
first ATP binding site (D1), i.e., D1-K266A and D1-E329Q,
are known to affect ATP binding and hydrolysis, resulting
in inactive forms of NSF (Whiteheart et al., 1994). To de-
termine the role of the ATP binding domains of NSF in
Rab5-mediated endocytosis, we coinjected Rab5:Q79L and
different NSF mutant proteins into oocytes and followed
HRP uptake. The results in Fig. 5 
 
b
 
 demonstrate that His6
D1-E329Q and His6 D1-K266A significantly inhibit HRP
uptake mediated by Rab5:Q79L, indicating that ATP hy-
drolysis and binding are required for NSF activity and
Rab5-mediated endocytosis.
Figure 3. Effect of Rab5 and
its mutants on endocytosis in
oocytes. (a) Oocytes were in-
jected with 100 ng each of the
indicated proteins, and the
uptake was carried out as de-
scribed in Fig. 1. The results
were expressed as percent-
age of control (200 ng/oocyte) 6 SD. (b) Oocytes were injected
with 100 ng of Rab5:Q79L or Rab5:DC4 in 50 nl of microinjec-
tion buffer and incubated for 2 h at 188C. The cells were lysed,
and crude membrane and cytosolic fractions were prepared by
centrifuging at 70,000 rpm for 15 min. Each fraction (5 mg) was
separated by SDS-PAGE and transferred onto nitrocellulose,
and Rab5 protein was localized using polyclonal Rab5-specific
antibodies (Alvarez-Dominguez et al., 1996).
Figure 4. Inhibition of HRP uptake by anti-Rab5 antibody. The
oocytes were injected with Rab5:Q79L (100 ng) alone or with
anti-Rab5 antibody (200 ng). HRP uptake was followed as de-
scribed in Fig. 1. Results are expressed as percentage of control
uptake (150 ng per oocyte) from the average of eight experi-
ments.
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Figure 5. Effect of NSF on HRP uptake by oocytes. (a) Cells
were injected with either 100 ng of Rab5:Q79L with or without
anti-NSF (200 ng) antibody. Uptake was carried out as described
in Materials and Methods. Results were expressed as percentage
of control uptake (180 ng/oocyte) from the average of eight ex-
periments. (b) Oocytes were injected with 75 ng of Rab5:Q79L
alone or with 100 ng of NSF and its mutants as indicated. Uptake
was determined as described, and the results are expressed as
percentage of control (220 ng per oocyte) uptake. Figure 6. Rab7-mediated uptake of HRP by oocytes. Oocytes
were injected with 100 ng of the indicated proteins and uptake
was carried out with HRP-FITC for 1 h in the dark (1 mg/ml).
Subsequently, the cells were washed three times with MBS, incu-
bated in the dark for another 1 h, and then observed under the
confocal microscope.
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Effect of Rab7 and Its Mutants on HRP Uptake
 
As indicated above, injection of Rab7:WT (100 ng) into
oocytes produced a marked stimulation in HRP uptake
(Fig. 2). To characterize the effect of Rab7 on endocytosis,
we examined the effect of Rab7 on the uptake HRP-FITC
by confocal microscopy. The results presented in Fig. 6
show substantial increases in fluorescence when the cells
were injected with Rab7:WT protein. Cells injected with
Rab7:T22N appeared very similar to control cells. In fact,
injection of Rab7:T22N showed significant inhibition of
HRP-FITC uptake (data not shown). In control and Rab7:
T22N injected cells, most of the staining was observed
near the plasma membrane, presumably in early endoso-
mal compartments. In Rab7:WT-injected cells, it is evident
that HRP-FITC is localized to larger vesicles and much
deeper into the cells, possibly reflecting the transport of
the marker proteins into later compartments. To further
confirm the effect of Rab5 and Rab7 on the endocytic
pathway at the EM level, oocytes were injected with Rab5:
WT and Rab7:WT, and then allowed to internalize WGA–
gold particles for 60 min. The cells were then fixed and
prepared for EM. Oocytes injected with Rab5 had sub-
stantially more early endosome–like vesicular structures,
whereas a significant labeling of large multivesicular endo-
somes (1–1.5 
 
m
 
m) deeper inside the cells was observed
when cells were injected with Rab7:WT. These data sug-
gest that Rab7 induced the transport to a late endosome/
prelysosome compartment. About 180–200 large multive-
sicular compartments were observed per square millime-
ter only in oocytes injected with Rab7:WT protein (data
not shown).
 
Differential Kinetics of Rab5 and Rab7 on Endocytosis 
in Oocytes
 
Rab5 is an early endosomal Rab that regulates endosome
fusion, whereas Rab7 is localized to the late endosomal
compartment (Wichmann et al., 1992; Schimmoller et al.,
1993; Feng et al., 1995). Our data indicate that both pro-
teins stimulate HRP uptake in oocytes, suggesting an ef-
fect of both proteins on the early endocytic pathway. To
check the effect of Rab5 and Rab7 on later events, we de-
veloped a more direct biochemical assay to measure the
degradation of internalized HRP after injection of the test
proteins, as a measure of transport to a degradative or late
compartment. In this assay, oocytes were preloaded with
HRP for 1 h at 18
 
8
 
C. HRP activity was then followed over
time after injecting Rab5 or Rab7 proteins. The results
presented in Fig. 7 
 
a
 
 show that 
 
z
 
80% of the HRP activity
is lost within 2 h when the cells were injected with Rab7:
WT protein. In contrast, most of the HRP activity is re-
tained when the cells were injected with Rab5:WT protein,
much like control cells. Thus, Rab7 not only promotes the
internalization of HRP but also mediates apparent rapid
degradation possibly by transferring internalized mole-
 
Figure 7.
 
Rab7-mediated inactivation/degradation of HRP by
oocytes. (
 
a
 
) Oocytes were preloaded with HRP by incubating
with HRP (2 mg/ml) for 1 h at 18
 
8
 
C. Preloaded cells were washed
and incubated with 100 
 
m
 
M monensin or control buffer as indi-
cated for 1 h at 18
 
8
 
C. The cells were then injected with 100 ng of
the respective fusion proteins. HRP activity present in the cells
was measured after a 2-h incubation at 18
 
8
 
C. Results are ex-
pressed as percentage of control (110 ng HRP/oocyte) from the
average of eight experiments. (
 
b
 
) Oocytes were incubated with
 
125
 
I-HRP (0.5 mg/ml; 2 
 
3
 
 10
 
5
 
 cpm/
 
m
 
g) for 1 h at 18
 
8
 
C and washed
three times to remove unbound radioactivity. Subsequently, the
cells were injected with 100 ng of Rab7:WT protein or control
buffer, and nine oocytes were incubated in 300 
 
m
 
l of MBS for 2 h
at 18
 
8
 
C. Oocytes were washed and solublized in PBS containing
0.1% Triton X-100, and TCA-soluble and -precipitable radioac-
tivity was determined in cell lysates and media. Results are ex-
pressed as ng of HRP associated with or degraded by the cells.
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cules to a late compartment. Moreover, when the Rab7:
WT-injected/HRP-preloaded cells were incubated in the
presence of monensin (100 
 
m
 
M), 
 
z
 
80% of the HRP inacti-
vation was prevented. We speculate that monensin pre-
vents the inactivation and degradation of HRP either by
blocking the transport to the later compartment or by in-
creasing the pH of the lysosome-like compartment, which
in turn inhibits the inactivation and/or degradation of HRP.
To examine the degradation of internalized HRP, oo-
cytes were incubated with 
 
125
 
I-HRP for 60 min, after which
they were injected with control buffer or Rab7. The data
presented in Fig. 7 b show the distribution of internalized
125I-HRP in oocytes after injecting Rab7:WT protein into
the cells. 43% of the HRP was degraded by the Rab7:WT
protein–injected cells. In contrast, only 25% of the pre-
loaded HRP was degraded when the cells were injected
with control buffer. In both sets of cells, the same amount
of the TCA-precipitable radioactivity (50%) was recov-
ered in the medium, suggesting that a substantial amount
of recycling occurs in this preparation. However, Rab7 did
not induce or enhance recycling or regurgitation of the
HRP to the medium.
Effects of Rab5- and Rab7-negative Mutants on
Rab5-stimulated Endocytosis
We next examined the effects of the dominant-negative
mutants of Rab5 and Rab7 to determine which acts first in
the sequence. Injection of Rab5:WT into oocytes stimu-
lated HRP uptake (Fig. 8 a) by about twofold. Coinjection
of the Rab7 dominant-negative mutant (Rab7:T22N) with
Rab5 had no effect on the Rab5-mediated stimulation of
uptake. However, coinjection of the Rab5 dominant-nega-
tive mutant (Rab5:S34N) with Rab5:WT significantly at-
Figure 8. Rab5 regulation of endocytosis is upstream of Rab7. (a)
Rab5 proteins were injected alone (50 ng) or in combination with
both mutants (100 ng) of Rab5 and Rab7. (b) Rab7 proteins (50 ng)
were injected alone or in combination with both mutants (100 ng)
of Rab5 and Rab7. Results are expressed as percentage of control
uptake by uninjected oocytes (average of eight experiments).
Figure 9. Rab5- and Rab7-coinjected cells produced additive ef-
fects. Oocytes were injected with 50 ng of Rab5 and Rab7 alone
or in combination and incubated for 2 h at 188C. The cells were
incubated with 2 mg/ml of HRP for 1 h at 188C to determine the
rate of HRP uptake. Results are expressed as percentage of up-
take per oocyte with respect to control (205 ng per oocyte) 6SD
(average of eight experiments).
 o
n
 N
ovem
ber 21, 2011
jcb.rupress.org
D
ow
nloaded from
 
Published March 24, 1997
The Journal of Cell Biology, Volume 136, 1997 1234
tenuated the Rab5:WT effect. On the other hand, injection
of Rab7:WT produced a threefold increase in uptake, as
shown in Fig. 8 b, and coinjection of the Rab7 dominant-
negative mutant with Rab7:WT blocked the Rab7:WT ef-
fect. Interestingly, Rab5:S34N inhibited Rab7:WT-induced
endocytosis. Moreover, Rab7:T22N and Rab5:S34N inhib-
ited uptake when injected alone. Lastly, we examined the
additive effects of Rab5 and Rab7 on endocytosis when
coinjected. Injection of Rab5 and Rab7 separately in-
creased endocytosis. Coinjection of Rab5 and Rab7 pro-
duced an additive effect on uptake of HRP (Fig. 9).
Discussion
The Xenopus laevis oocyte is an excellent cell model for
investigating the mechanisms and the regulation of en-
docytosis (Opresko et al., 1980). Several characteristics of
receptor-mediated endocytosis have been explored in the
frog oocyte (Wall and Patel, 1987), and ultrastructural and
biochemical studies have shown that intracellular trans-
port of internalized ligands occurs via fusion between
early endocytic vesicles and consecutively enlarged endo-
somes (Busson et al., 1989). In brief, these studies show
that vitellogenin, the precursor to stored yolk protein, is
taken up by receptor-mediated endocytosis. Internalized
vitellogenin receptor–ligand complexes are selectively pro-
teolyzed and sequestered from the normal endocytic path-
way with transport to yolk platelets. Selective targeting to
the storage pathway appears to be dependent both on
receptor occupancy and on selective ligand proteolysis
(Opresko and Karpf, 1987). Fluid phase markers, on the
other hand, in the absence of vitellogenin, are routed to
the degradative pathway. In the work described in this pa-
per, we have used HRP as a fluid phase marker.
In the last few years, it has become apparent that GTP
binding proteins play an important role in endocytosis,
and that a series of GTPases act in concert to effect trans-
port from cell surface to lysosomes or the TGN. A large
number of studies have shown that GTPgS can impair
transport by interfering with budding or the fusion events,
consistent with the conclusion that a large repertoire of
GTPases is required for efficient endocytosis (Gomperts
and Fernandez, 1985; Mayorga et al., 1989; Goda and Pfef-
fer, 1988; Damke et al., 1995).
Numerous reports indicate that several small GTPases
regulate endocytosis. Most of these studies have employed
transient overexpression of proteins using recombinant vi-
rus encoding the proteins of interest. This approach has
been extremely useful in studying transport but is some-
what limited because usually only one variable can be
changed at a time. We have developed an in vivo assay by
microinjection of purified proteins into Xenopus oocytes
followed by endocytosis of HRP. This approach takes ad-
vantage of the high endocytic capacity of oocytes and al-
lows one to examine the effect of one or more proteins
that can be injected simultaneously. These studies have led
to some unexpected findings.
Two experiments, one with GTPgS and another with
aluminum fluoride, indicate that one or more GTPases are
involved in oocyte endocytosis and that GTP hydrolysis by
at least one GTPase is required. Aluminum fluoride is a
potent and reversible activator of the heterotrimeric GTP
binding proteins (Chabre, 1990; Colombo et al., 1994), al-
though recent experiments (Mittal et al., 1996) indicate
that, under certain circumstances, low molecular weight
GTPases can be affected by AlF4. Heterotrimeric GTPases
have been implicated in transport along the secretory
pathway (Burgoyne, 1992) and in endocytosis (Colombo
et al., 1992).
Rab4 and Rab5 are associated with early endosomes,
and Rab5, in particular, has been shown to play a role in
the regulation of endocytosis. As shown in Fig. 3 a, Rab5:
Q79L, a GTPase-defective mutant, enhances HRP uptake.
This result suggests that the GTP form of Rab5 is the mo-
lecular switch for endocytosis in oocytes as reported for
other cells (Barbieri et al., 1994; Stenmark et al., 1994).
Rab5:Q79L has been shown to induce HRP uptake in
BHK cells (Li et al., 1994) and to enhance fusion between
early endosomes in an in vitro reconstitution assay (Sten-
mark et al., 1994; Barbieri et al., 1994). Thus, enhanced up-
take of HRP by oocytes is probably due to enhanced fu-
sion between early endosomes. In contrast, Rab5:S34N,
the dominant-negative mutant, inhibited HRP uptake.
This is in agreement with the observation that Rab5:S34N
inhibits both endocytosis, when overexpressed in mamma-
lian cells, and in vitro endosome fusion. The inhibition of
HRP uptake by Rab5:S34N may be due to competition for
the Rab5-specific exchange factor, as suggested for ras-
specific GEF (Feig and Cooper, 1988; Hwang et al., 1993;
Schweighoffer et al., 1993).
The COOH-terminal motif of Rab proteins serves as a
recognition site for isoprenylation that is important for
membrane attachment and biological function (Li et al.,
1994; Burstein et al., 1992). It has been shown that dele-
tion of three or four residues from the COOH-terminal
domain of Rab5 completely abolishes prenylation. The
data presented in the Fig. 3 a show that Rab5:DC did not
significantly affect HRP uptake in oocytes. This is proba-
bly due to the fact that this protein is not prenylated and
unable to bind to target membranes. This was further con-
firmed by the Western blot analysis (Fig. 3 b). A band cor-
responding to Rab5 was detected in the membrane prepa-
ration of oocytes injected with Rab5:Q79L but not Rab5:
DC4 where most of the protein was detected in the cytosol.
In vitro prenylation experiments confirmed that oocyte cy-
tosol has the capacity, in the presence of added substrate,
to prenylate Rab GTPases (data not shown). These results
indicate that the oocyte has the ability to carry out prenyl-
ation, and that COOH-terminal isoprenylation is required
for the binding of the Rab proteins and for their biological
activity.
To further characterize endocytosis in microinjected oo-
cytes, we examined NSF. NSF fusion protein is required
for efficient fusion of endosomes in vitro. Mutants of NSF
that fail to bind or to hydrolyze ATP are effective inhibi-
tors of endosome fusion in vitro (Colombo et al., 1996).
NSF and associated SNAP molecules (Wilson et al., 1992;
Sollner et al., 1993) are required in multiple intracellular
vesicle fusion events (Becker et al., 1989; Diaz et al., 1989;
Sztul et al., 1993; Sogaard et al., 1994). The results pre-
sented in Fig. 5 a show that anti-NSF antibody inhibits
Rab5:Q79L-induced HRP uptake in oocytes. (Western blot
experiments not shown indicate that the mAb used recog-
nizes a frog protein of the same apparent molecular weight
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as NSF.) Injection of anti-NSF into control cells produced
a modest decrease in uptake. The role of NSF was further
confirmed by coinjecting wild-type NSF or NSF mutants
(D1E-Q, D1K-A) along with Rab5:Q79L. The results show
that NSF activates endocytosis of HRP mediated by Rab5
and suggest that NSF may be rate limiting in Rab5-sensi-
tive pathways. This is the first report of activation of a
transport pathway by NSF in vivo. To confirm the role of
NSF, we used two NSF mutants that are known to block
NSF function. These mutant proteins inhibited uptake, sug-
gesting that ATP binding and hydrolysis by NSF is re-
quired for function in oocytes as in mammalian cells (White-
heart et al., 1994). However, why anti-NSF antibodies
effectively block Rab-induced endocytosis and yet only mod-
estly inhibit control uptake is unclear. It is likely that en-
dogenous NSF and endogenous Rab GTPases are more
efficient than the injected mammalian counterparts. This
might explain why antibody inhibition of uptake is only
modest in control cells since the antibody would be com-
peting with endogenous factors for binding to NSF. Simi-
larly, exogenous Rabs might be more easily competing for
interaction with the docking and fusion machinery than
endogenous Rabs by the anti-NSF antibody.
Recently, it has been shown in mammalian cells that
Rab7 regulates transport between the early and late endo-
somes (Feng et al., 1995). Similar results were also ob-
tained in yeast using Ypt7, a yeast homologue of mamma-
lian Rab7. Schimmoller and Riezmann (1993) have shown
that Ypt7 regulates the transport between the late endo-
some to the vacuole. Moreover, it has been shown that
Ypt7 is also involved in the homotypic fusions between the
vacuole in the yeast (Hass et al., 1995; Mayer et al., 1996).
All these studies have shown that Rab7 in mammalian
cells or Ypt7 in yeast initiates the degradation of the
marker proteins by enhancing transport to a late endo-
some/prelysosome or lysosomal compartment. Our data
demonstrate that injected Rab7 WT stimulates HRP up-
take. Rab7:T22N, the dominant-negative mutant of Rab7
(Feig et al., 1988; Nuoffer et al., 1994; Riederer et al., 1994),
was found to be mildly inhibitory for HRP uptake when
injected alone but was fully able to block the stimulatory
effect of Rab7. As outlined above for inhibition by anti-
NSF antibodies, it is likely that the exogenous mammalian
Rab7-negative mutant would more effectively antagonize
injected mammalian wild-type Rab7 than the correspond-
ing endogenous Rab. The results presented in Fig. 7 a
show that when Rab7 was injected into HRP preloaded
cells, only 20% of the injected HRP activity was recovered
at the indicated times in Rab7:WT-injected cells compared
with controls. This rapid inactivation of HRP may be due
to loss of enzymatic activity, actual degradation, or both.
In Fig. 7 b, we show that Rab7-injected cells degrade 125I-
HRP more rapidly than control cells, but the degradation
was not commensurate with the loss of HRP activity in
Rab7-injected cells. Thus, the loss of HRP activity in Rab7-
injected cells is probably due to inactivation and degrada-
tion of the marker protein. The results in Fig. 7 b also con-
firm that the loss of activity in Rab7-injected cells is not
due to the recycling or regurgitation of HRP. Rab7 proba-
bly mediates the rapid degradation of the marker protein
by stimulating transport to a late endosome/prelysosomal
compartment (Fig. 7). Thus, kinetically, Rab7 function is
different from that of Rab5 because the latter does not
stimulate inactivation. The rapid inactivation of HRP in
Rab7-injected cells is effectively blocked by monensin.
Monensin may block the transport of the marker protein
from an early compartment to the degradative compart-
ment, or it may inhibit the degradation of the ligand by in-
creasing the pH of the lysosome-like compartment. The
latter is consistent with the finding that monensin blocks
the transport of markers to a later compartment described
by Opresko and Karpf (1987). An effect of Rab7 on trans-
port to late compartments is further strengthened by local-
ization of WGA–gold in large multivesicular endosomes
deep inside the oocyte when the cells were injected with
Rab7:WT. These data are consistent with that of Wall and
colleagues (Wall and Patel, 1987), who demonstrate that
multivesicular bodies are found along the endocytic path-
way. One issue that remains unresolved is whether the degra-
dation of the marker protein occurs in late endosomes or
lysosomes. GTPgS has been shown to block the transport
from late endosomes to lysosomes, implicating GTPases in
this process (Mullock et al., 1994). It is also possible that
Rab7 is involved in both processes. Interestingly, homo-
typic fusion of the vacuole has been shown to require Ypt7
(Hass et al., 1995), and recently Rab7 was found, in part,
to be localized in lysosomes (Meresse et al., 1995).
The results with the Rab coinjection experiments sug-
gest that Rab7 mediates endocytosis through the early en-
dosome and that the effect of Rab7 is downstream of
Rab5. Similar results have been reported in the yeast
where Ypt51p, Ypt52p, and Ypt53p, functional homo-
logues of mammalian Rab5, mediate the degradation of
the yeast pheromone a-factor via delivery to the vacuole.
A null Ypt7 mutant delayed the onset of a-factor degrada-
tion threefold, while a triple mutation Ypt51,Ypt52,Ypt53
delayed a-factor degradation more than sixfold (Singer-
Kruger et al., 1994; Wichmann et al., 1992). The fact that
a-factor is accumulated in the triple mutant in the early
endosome, whereas the Ypt7 mutant accumulated in the
late endosome, suggested that Ypt51 function is upstream
of Ypt7 (Schimmoller and Riezman, 1993). These conclu-
sions are similar to our findings in oocytes where we show
that Rab7-mediated uptake is blocked by the Rab5-nega-
tive mutant, but the Rab5-mediated uptake remains unaf-
fected in the presence of the Rab7-negative mutant. We
speculate that Rab5 fills an intracellular compartment, per-
haps an early endosomal sorting compartment. Internal-
ized solute present in the early endosomal compartment
may recycle to the cell surface or be transported to a later
compartment en route to lysosomes. Rab5 would be ex-
pected to increase the flux of ligand through the early
compartment. Rab7 stimulates transport from the early
endosome to a later compartment where inactivation and/or
degradation occurs. If Rab7 were rate limiting in the pathway
and the magnitude of the Rab7 effect was dependent on the
concentration of solute or ligand present in the early endo-
somal compartment, Rab7 would be expected to increase en-
docytosis and to act additively with Rab5. The relationship
between sequentially acting Rabs, the levels of expression,
the use of common factors (e.g., GDP dissociation inhibitor),
and the regulation by respective guanine nucleotide exchange
factors poses interesting and important questions that con-
cern the overall regulation of intracellular transport.
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